Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2025

Dec 30, 2025

34975_dirs_2025-12-30_19cabc48-a7a9-481c-b17c-7cced933125c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2025-12-17

Reporting Person: Snider William (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-12-17 Common Stock A 110000 $0.00 Acquired 110000 Direct

Footnotes

F1: Represents an award of 110,000 restricted stock units that fully vest on December 17, 2026.